During our time together, you’ll hear from leaders in AD research, advocacy, policy and industry explore the socioeconomic impact of Alzheimer’s disease and new opportunities for the global community to stop this growing pandemic. Held on the eve of the World Health Assembly, this dialogue will shine a spotlight on why advancing investment, innovation and policy solutions in Alzheimer’s is so critical.

We are grateful to our esteemed speakers and panelists:

U.S. Representative Don Beyer (D-VA)
Keynote

Dolors Montserrat, Member, European Parliament; 
Former Minister, Health, Social Services and Equality, Spain
Keynote

Surya Kolluri, Managing Director, Head of Thought Leadership, Bank of America
Moderator

Rhoda Au, Professor, Boston University

David Bloom, Professor, 
Harvard T.H. Chan School of Public Health

Phyllis Barkman Ferrell, 
Global Head, External Engagement, Alzheimer’s Disease & Neurodegeneration 
Eli Lilly & Company

Lori Frank, Senior Behavioral Scientist, RAND Corporation

Youssef Hayek, Senior Consultant, Shift Health

Carolee Lee, CEO and Founder, Women’s Health Access Matters (WHAM!)

Christopher J.L. Murray, Director, 
Institute for Health Metrics and Evaluation

George Vradenburg, Convener, The Global CEO Initiative on Alzheimer’s Disease;
Co-Chair, Davos Alzheimer’s Collaborative 

We welcome you to share the registration link with your networks.
 

The Virtual Lausanne Dialogue is a series of convenings focused on identifying barriers to stopping Alzheimer’s and setting solution paths for action. This convening is hosted by The Global CEO Initiative on Alzheimer’s Disease in partnership with the World Economic Forum and the Davos Alzheimer’s Collaborative.

Follow CEOi on  Twitter and LinkedIn